241 related articles for article (PubMed ID: 27709355)
1. Rapidly dissolving polymeric microneedles for minimally invasive intraocular drug delivery.
Thakur RR; Tekko IA; Al-Shammari F; Ali AA; McCarthy H; Donnelly RF
Drug Deliv Transl Res; 2016 Dec; 6(6):800-815. PubMed ID: 27709355
[TBL] [Abstract][Full Text] [Related]
2. Influence of molecular weight on transdermal delivery of model macromolecules using hydrogel-forming microneedles: potential to enhance the administration of novel low molecular weight biotherapeutics.
Hutton ARJ; McCrudden MTC; Larrañeta E; Donnelly RF
J Mater Chem B; 2020 May; 8(19):4202-4209. PubMed ID: 32292995
[TBL] [Abstract][Full Text] [Related]
3. Dissolving polymeric microneedle arrays for electrically assisted transdermal drug delivery.
Garland MJ; Caffarel-Salvador E; Migalska K; Woolfson AD; Donnelly RF
J Control Release; 2012 Apr; 159(1):52-9. PubMed ID: 22265694
[TBL] [Abstract][Full Text] [Related]
4. Corneal delivery of besifloxacin using rapidly dissolving polymeric microneedles.
Bhatnagar S; Saju A; Cheerla KD; Gade SK; Garg P; Venuganti VVK
Drug Deliv Transl Res; 2018 Jun; 8(3):473-483. PubMed ID: 29288357
[TBL] [Abstract][Full Text] [Related]
5. Nanosuspension-loaded dissolving bilayer microneedles for hydrophobic drug delivery to the posterior segment of the eye.
Wu Y; Vora LK; Mishra D; Adrianto MF; Gade S; Paredes AJ; Donnelly RF; Singh TRR
Biomater Adv; 2022 Jun; 137():212767. PubMed ID: 35929230
[TBL] [Abstract][Full Text] [Related]
6. Optimization of stereolithography 3D printing of microneedle micro-molds for ocular drug delivery.
Fitaihi R; Abukhamees S; Chung SH; Craig DQM
Int J Pharm; 2024 Jun; 658():124195. PubMed ID: 38703935
[TBL] [Abstract][Full Text] [Related]
7. Rapidly dissolving bilayer microneedles enabling minimally invasive and efficient protein delivery to the posterior segment of the eye.
Wu Y; Vora LK; Donnelly RF; Singh TRR
Drug Deliv Transl Res; 2023 Aug; 13(8):2142-2158. PubMed ID: 35713782
[TBL] [Abstract][Full Text] [Related]
8. Rapidly Dissolving Trans-scleral Microneedles for Intraocular Delivery of Cyclosporine A.
Alrbyawi H; Annaji M; Fasina O; Palakurthi S; Boddu SHS; Hassan N; Tiwari AK; Suryawanshi A; Babu RJ
AAPS PharmSciTech; 2024 Feb; 25(2):28. PubMed ID: 38302687
[TBL] [Abstract][Full Text] [Related]
9. Coated microneedles for drug delivery to the eye.
Jiang J; Gill HS; Ghate D; McCarey BE; Patel SR; Edelhauser HF; Prausnitz MR
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4038-43. PubMed ID: 17724185
[TBL] [Abstract][Full Text] [Related]
10. Comparative efficacy evaluation of different penetration enhancement strategies for dermal delivery of poorly soluble drugs - A case with sertaconazole nitrate.
Bubić Pajić N; Vucen S; Ilić T; O'Mahony C; Dobričić V; Savić S
Eur J Pharm Sci; 2021 Sep; 164():105895. PubMed ID: 34087357
[TBL] [Abstract][Full Text] [Related]
11. The combination of microneedles with electroporation and sonophoresis to enhance hydrophilic macromolecule skin penetration.
Petchsangsai M; Rojanarata T; Opanasopit P; Ngawhirunpat T
Biol Pharm Bull; 2014; 37(8):1373-82. PubMed ID: 24931312
[TBL] [Abstract][Full Text] [Related]
12. Long-acting nanoparticle-loaded bilayer microneedles for protein delivery to the posterior segment of the eye.
Wu Y; Vora LK; Wang Y; Adrianto MF; Tekko IA; Waite D; Donnelly RF; Thakur RRS
Eur J Pharm Biopharm; 2021 Aug; 165():306-318. PubMed ID: 34048879
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of microneedles-assisted in situ depot forming poloxamer gels for sustained transdermal drug delivery.
Khan S; Minhas MU; Tekko IA; Donnelly RF; Thakur RRS
Drug Deliv Transl Res; 2019 Aug; 9(4):764-782. PubMed ID: 30675693
[TBL] [Abstract][Full Text] [Related]
14. Depthwise-controlled scleral insertion of microneedles for drug delivery to the back of the eye.
Park SH; Jo DH; Cho CS; Lee K; Kim JH; Ryu S; Joo C; Kim JH; Ryu W
Eur J Pharm Biopharm; 2018 Dec; 133():31-41. PubMed ID: 30267835
[TBL] [Abstract][Full Text] [Related]
15. Rapidly dissolving microneedle patch of amphotericin B for intracorneal fungal infections.
Albadr AA; Tekko IA; Vora LK; Ali AA; Laverty G; Donnelly RF; Thakur RRS
Drug Deliv Transl Res; 2022 Apr; 12(4):931-943. PubMed ID: 34302273
[TBL] [Abstract][Full Text] [Related]
16. Fabrication of a novel partially dissolving polymer microneedle patch for transdermal drug delivery.
Lee IC; He JS; Tsai MT; Lin KC
J Mater Chem B; 2015 Jan; 3(2):276-285. PubMed ID: 32261948
[TBL] [Abstract][Full Text] [Related]
17. Two-layered dissolving microneedles for percutaneous delivery of peptide/protein drugs in rats.
Fukushima K; Ise A; Morita H; Hasegawa R; Ito Y; Sugioka N; Takada K
Pharm Res; 2011 Jan; 28(1):7-21. PubMed ID: 20300802
[TBL] [Abstract][Full Text] [Related]
18. Transdermal delivery of relatively high molecular weight drugs using novel self-dissolving microneedle arrays fabricated from hyaluronic acid and their characteristics and safety after application to the skin.
Liu S; Jin MN; Quan YS; Kamiyama F; Kusamori K; Katsumi H; Sakane T; Yamamoto A
Eur J Pharm Biopharm; 2014 Feb; 86(2):267-76. PubMed ID: 24120887
[TBL] [Abstract][Full Text] [Related]
19. Investigation and Optimization of Hydrogel Microneedles for Transdermal Delivery of Caffeine.
Chandran R; Mohd Tohit ER; Stanslas J; Salim N; Tuan Mahmood TM
Tissue Eng Part C Methods; 2022 Oct; 28(10):545-556. PubMed ID: 35485888
[TBL] [Abstract][Full Text] [Related]
20. Dissolving polymeric microneedle arrays for enhanced site-specific acyclovir delivery.
Pamornpathomkul B; Ngawhirunpat T; Tekko IA; Vora L; McCarthy HO; Donnelly RF
Eur J Pharm Sci; 2018 Aug; 121():200-209. PubMed ID: 29777854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
